Accelerator Fund

Managed by the Pittsburgh Life Sciences Greenhouse

  • Home
  • About The Fund
    • Investment Focus
    • Management Team
  • Portfolio
  • Investor Access
  • News
  • Contact Us
  • Home
  • Category Archives: "Cognition Therapeutics"

Archives: Cognition Therapeutics

Cognition Therapeutics Presenting Evidence for Elayta Synaptic Protection in Alzheimer’s Patients at Combined AAT-AD/PD Focus Meeting

Press Release

, March 14th, 2018

Cognition Therapeutics Co-Founder and CSO Susan Catalano to Present at Sachs Neuroscience Innovation Forum

Press Release

, January 4th, 2018

Cognition Therapeutics’ Alzheimer’s Disease Candidate CT1812 Meets Phase 1b/2a Study Objectives: Well Tolerated with Positive Influence on Biomarkers of Synapse Recovery

Press Release

, November 4th, 2017

Pharm company plans to start clinic trials of Alzheimer’s treatment by year-end

Pittsburgh Business Times

, September 9th, 2015

Cognition Therapeutics Completes Oversubscribed $12 Million Series B Financing

Press Release, September 8th, 2015

Developer of drugs to treat Alzheimer’s raises $12M

Pittsburgh Business Times

, August 5th, 2015

Categories

  • Accelerator Fund
  • Alung Technologies, Inc.
  • Carmell Therapeutics
  • ClearCount Medical Solutions
  • Cognition Therapeutics
  • Cohera Medical, Inc
  • Complexa, Inc.
  • Media Coverage
  • Medrobotics
  • Pittsburgh Life Sciences Greenhouse
  • Press Releases
  • Quantum OPS
  • Rinovum Women's Health
  • Wellbridge Health

Archives

  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011

Navigation

  • Home
  • About The Fund
    • Investment Focus
    • Management Team
  • Portfolio
  • Investor Access
  • News
  • Contact Us

Contact Us

James F. Jordan,
Managing Director

2425 Sidney Street
Pittsburgh, PA 15203

412-770-1648 – Direct
412-201-7370 – Office
412-770-1276 – Fax

© Copyright 2015 Pittsburgh Life Sciences Greenhouse and Accelerator Fund, LLC. All Rights Reserved.
Privacy Policy   |   Terms of Use
NVCA Member